Nouscom Appoints Adrian Woolfson, M.D., Ph.D as Chief Medical Officer

BASEL, Switzerland – 29th May 2018 Nouscom, an immuno-oncology company developing off-the-shelf and personalized neoantigen-based genetic cancer vaccines based on its clinically validated Exovax [...]

DATE: 04/16/2018 | JOURNAL: JAMA Oncology

Immune Profiling of Premalignant Lesions in Patients With Lynch Syndrome

ABSTRACT IMPORTANCE Colorectal carcinomas in patients with Lynch syndrome (LS) arise in a background of mismatch repair (MMR) deficiency, display a unique immune profile with upregulation of [...]

Okairos awarded by Swiss Biotech Association

The Swiss Biotech Association Honors Major Industry Achievements with Swiss Biotech Success Stories Basel, Switzerland, May 04, 2018 — On the occasion of its 20th anniversary, the Swiss [...]